(Q38060845)

28 August 2017

1 reference

title

Adaptation and clonal selection models of castration-resistant prostate cancer: current perspective (English)

1 reference

28 August 2017

1 reference

Muhammed Ahmed

1

1 reference

28 August 2017

Long-Cheng Li

series ordinal

2

1 reference

28 August 2017

language of work or name

1 reference

19 November 2012

1 reference

International Journal of Urology

28 August 2017

published in

1 reference

28 August 2017

volume

20

1 reference

28 August 2017

issue

4

1 reference

28 August 2017

page(s)

362-371

1 reference

Steroid hormone receptors in prostate cancer: a hard habit to break?

28 August 2017

cites work

1 reference

Androgen receptor: a key molecule in the progression of prostate cancer to hormone independence

21 January 2018

1 reference

Endocrine-induced regression of cancers

21 January 2018

1 reference

Molecular genetics of prostate cancer: new prospects for old challenges

21 January 2018

1 reference

Effects of intermittent androgen suppression on the stem cell composition and the expression of the TRPM-2 (clusterin) gene in the Shionogi carcinoma

21 January 2018

1 reference

Loss of androgen dependence is associated with an increase in tumorigenic stem cells and resistance to cell-death genes.

21 January 2018

1 reference

The biology of hormone refractory prostate cancer. Why does it develop?

21 January 2018

1 reference

Stem cells: The root of prostate cancer?

21 January 2018

1 reference

Inactivation of the tumor suppressor PTEN/MMAC1 in advanced human prostate cancer through loss of expression

21 January 2018

1 reference

Mutation and expression analysis of the putative prostate tumour-suppressor gene PTEN

21 January 2018

1 reference

Androgen receptor mutants detected in recurrent prostate cancer exhibit diverse functional characteristics

21 January 2018

1 reference

Increased AKT activity contributes to prostate cancer progression by dramatically accelerating prostate tumor growth and diminishing p27Kip1 expression

21 January 2018

1 reference

PTEN genomic deletion is an early event associated with ERG gene rearrangements in prostate cancer

21 January 2018

1 reference

Androgen receptor gene mutations in human prostate cancer

21 January 2018

1 reference

Androgen receptor signaling and mutations in prostate cancer

21 January 2018

1 reference

The role of androgen receptor mutations in prostate cancer progression.

21 January 2018

1 reference

The development of androgen-independent prostate cancer

21 January 2018

1 reference

Mechanisms underlying the development of androgen-independent prostate cancer.

21 January 2018

1 reference

Mutation of the androgen-receptor gene in metastatic androgen-independent prostate cancer

21 January 2018

1 reference

Chromosomal deletions and tumor suppressor genes in prostate cancer.

21 January 2018

1 reference

Integrative genomic profiling of human prostate cancer

21 January 2018

1 reference

Tenets of PTEN tumor suppression

21 January 2018

1 reference

Decreased NKX3.1 protein expression in focal prostatic atrophy, prostatic intraepithelial neoplasia, and adenocarcinoma: association with gleason score and chromosome 8p deletion.

21 January 2018

1 reference

Chromosomal aberrations in prostate cancer.

21 January 2018

1 reference

NKX3.1 as a marker of prostatic origin in metastatic tumors.

21 January 2018

1 reference

The Myc oncoprotein as a therapeutic target for human cancer

21 January 2018

1 reference

21 January 2018

MYC and Prostate Cancer

1 reference

Enhanced expression of the c-myc protooncogene in high-grade human prostate cancers

21 January 2018

1 reference

Overexpression of C-MYC oncogene in prostate cancer predicts biochemical recurrence

21 January 2018

1 reference

Nuclear MYC protein overexpression is an early alteration in human prostate carcinogenesis

21 January 2018

1 reference

Bcl-2 and the regulation of programmed cell death

21 January 2018

1 reference

Regulation of cell division cycle progression by bcl-2 expression: a potential mechanism for inhibition of programmed cell death

21 January 2018

1 reference

Expression of the Bcl-2 protein BAD promotes prostate cancer growth

21 January 2018

1 reference

Up-regulation of Bcl-2 is required for the progression of prostate cancer cells from an androgen-dependent to an androgen-independent growth stage

21 January 2018

1 reference

BCL2 protein is topographically restricted in tissues characterized by apoptotic cell death

21 January 2018

1 reference

A novel antisense oligonucleotide inhibiting several antiapoptotic Bcl-2 family members induces apoptosis and enhances chemosensitivity in androgen-independent human prostate cancer PC3 cells

21 January 2018

1 reference

Bcl-2 modulation to activate apoptosis in prostate cancer

21 January 2018

1 reference

Alteration of proliferation and apoptotic markers in normal and premalignant tissue associated with prostate cancer

21 January 2018

1 reference

Alteration of the Tumor Suppressor Gene p53 in a High Fraction of Hormone Refractory Prostate Cancer

21 January 2018

1 reference

p53 in prostate cancer: frequent expressed transition mutations

21 January 2018

1 reference

Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer.

21 January 2018

1 reference

Recurrent gene fusions in prostate cancer

21 January 2018

1 reference

Detection of TMPRSS2-ETS fusions by a multiprobe fluorescence in situ hybridization assay for the early diagnosis of prostate cancer: a pilot study

21 January 2018

1 reference

TMPRSS2-ERG gene fusion causing ERG overexpression precedes chromosome copy number changes in prostate carcinomas and paired HGPIN lesions

21 January 2018

1 reference

Increased gene copy number of ERG on chromosome 21 but not TMPRSS2-ERG fusion predicts outcome in prostatic adenocarcinomas

21 January 2018

1 reference

A tumour stem cell hypothesis for the origins of prostate cancer

21 January 2018

1 reference

Stem cells, cancer, and cancer stem cells

21 January 2018

1 reference

Cellular origin of cancer: dedifferentiation or stem cell maturation arrest?

21 January 2018

1 reference

On the stem cell origin of cancer

21 January 2018

1 reference

Revisiting the concept of cancer stem cells in prostate cancer.

21 January 2018

1 reference

Leukaemia stem cells and the evolution of cancer-stem-cell research.

21 January 2018

1 reference

Prospective identification of tumorigenic prostate cancer stem cells

21 January 2018

1 reference

Stem cell genes in androgen-independent prostate cancer

21 January 2018

1 reference

Cancer stem cell subsets and their relationships

21 January 2018

1 reference

A luminal epithelial stem cell that is a cell of origin for prostate cancer

21 January 2018

1 reference

Stem-like cells with luminal progenitor phenotype survive castration in human prostate cancer

21 January 2018

1 reference

Comprehensive assessment of TMPRSS2 and ETS family gene aberrations in clinically localized prostate cancer

21 January 2018

1 reference

Die TMPRSS2-ETS-Genfusion beim Prostatakarzinom

21 January 2018

1 reference

TMPRSS2-ERG Fusion Prostate Cancer: An Early Molecular Event Associated With Invasion

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/IJU.12005

1 reference

28 August 2017

1 reference